biosimilars

Are Scare Tactics Being Used to Avoid Biosimilar Competition?
BioSpace
Sat, 01/12/19 - 11:39 am
biosimilars
competition
drug marketing
FDA approves Celltrion's Herceptin biosimilar
BioCentury
Sun, 12/16/18 - 12:23 am
FDA
Herceptin
biosimilars
Celltrion
HER2-positive metastatic breast cancer
FDA Rolls Out Expectations for Biosimilars, Soon-to-Be Biologics
RAPS.org
Wed, 12/12/18 - 12:17 am
FDA
biosimilars
biologics
BPCIA
Biosimilar makers back Pfizer in call to end misleading brand marketing
BioCentury
Tue, 12/4/18 - 11:39 pm
FDA
Pfizer
biosimilars
AbbVie inks Humira patent deal No. 7, delaying Pfizer's U.S. biosim launch until late 2023
Fierce Pharma
Fri, 11/30/18 - 12:36 pm
AbbVie
biosimilars
Pfizer
Humira
patents
Spotlight on drug pricing could be catalyst for change in US biosimilar landscape
Endpoints
Fri, 11/30/18 - 12:23 pm
drug pricing
biosimilars
FDA approves first biosimilar for NHL
BioCentury
Thu, 11/29/18 - 12:00 am
Celltrion
Teva Pharmaceutical
non-Hodgkin's lymphoma
Truxima
biosimilars
rituximab
Boehringer dropping ex-U.S. biosimilars programs
BioCentury
Wed, 11/28/18 - 11:49 pm
Boehringer Ingelheim
biosimilars
Momenta Moves On
Motley Fool
Fri, 11/16/18 - 07:58 pm
Momenta
earnings
biosimilars
M281
M254
Novartis Calls for FDA Enforcement Against Biosimilar Misinformation
RAPS.org
Thu, 11/15/18 - 11:42 pm
Novartis
FDA
biosimilars
citizen petitions
Pfizer launches biosimilar version of Amgen's Epogen
Biopharma Dive
Wed, 11/14/18 - 11:45 pm
Pfizer
biosimilars
Amgen
Epogen
JNJ
Procrit
anemia
The dynamics of the biosimilars market
GoinPharma
Sun, 11/11/18 - 09:01 pm
biosimilars
Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount
Reuters
Fri, 11/9/18 - 12:03 pm
Coherus Biosciences
Amgen
biosimilars
Neulasta
Boehringer Cites ‘Massive’ Number of Patents in Humira Biosimilar Suit
RAPS.org
Fri, 11/9/18 - 11:34 am
Boehringer Ingelheim
AbbVie
Humira
patents
biosimilars
AbbVie staves off 6th Humira biosimilar in US
Biopharma Dive
Wed, 11/7/18 - 10:44 pm
AbbVie
Humira
biosimilars
Momenta Pharmaceuticals
Biogen Ups Investment in Biosimilar Drug Maker Samsung Bioepis by $700 Million
BioSpace
Wed, 11/7/18 - 12:29 pm
Biogen
Samsung Bioepis
biosimilars
Novartis' Sandoz calls it quits on Rituxan biosimilar after FDA requests more data
Fierce Pharma
Mon, 11/5/18 - 11:53 am
Novartis
Sandoz
FDA
biosimilars
Roche
Rituxan
Coherus looks to disrupt Amgen’s $4B Neulasta franchise as analysts look for a deep discount on its copycat price
Endpoints
Mon, 11/5/18 - 09:56 am
Coherus
Neulasta
Mylan
biosimilars
Amgen
Novartis abandons effort for U.S. approval of biosimilar rituximab
Yahoo/Reuters
Sat, 11/3/18 - 12:39 pm
Novartis
Sandoz
rituximab
biosimilars
Roche
Amgen reckons with biosimilar and pricing pressures
Biopharma Dive
Wed, 10/31/18 - 07:14 pm
Amgen
earnings
biosimilars
Aimovig

Pages